Prescribing pattern of antidiabetic drugs in type 2 diabetes mellitus at a tertiary care hospital in Eastern India

Alak K. Das, Aishwarya Dutta, Animesh Maitiy, Dipak K. Sarkar, Manab Nandy, Jinia Ghosh


Background: Chronic hyperglycemia of diabetes mellitus (DM) is associated with long-term damage, dysfunction and failure of various organs, especially the eyes, kidneys, nerves, heart and blood vessels. We aimed to evaluate the prescribing pattern of antidiabetic drugs among Type 2 DM (T2DM) outpatients in Medical College, Kolkata.

Methods: A cross sectional study was conducted over a period of three months in the Department of Pharmacology and Department of Endocrinology, Medical College, Kolkata. Detailed information of the participants regarding demography, medical history, duration of diabetes, family history of diabetes, prescribed antidiabetic medicines, comorbid conditions and associated medications were evaluated.

Results: A total of 305 subjects with T2DM were included and 516 prescriptions were analyzed. 57% of the subjects were male. Majority of patients the were in the age group of 51-60 (37.7%) years. Most of them had history of diabetes between 1-5 years (46.26%) and most common comorbid condition was hypertension. The average number of antidiabetic medicines per prescription was 2.90. Antidiabetic drug was prescribed as monotherapy (5.23%) as well as combination of two (32.36%), three (38.17%), four (16.47%), five (7.17%) and six (0.58%) anti-diabetic drugs combinations. Among the oral antidiabetic (OAD) agents, metformin was most commonly prescribed (92.44%) while the most commonly prescribed injectable antidiabetic medicine was lispromix insulin (27.13%).

Conclusions: The antidiabetic medicine prescribing trend appeared to be shifting towards combination therapy. Through a thorough understanding of the existing prescribing patterns, attempts may be made to improve the quality and efficiency of drug therapy.


Antidiabetic drug, Drug utilization, Type 2 diabetes mellitus

Full Text:



Powers AC. Diabetes mellitus. In: Kasper DL, Fauci AS, Longo DL, Ameson JL, Loscalzo J, Hauser SL, et al, eds. Harrison’s Principles of Internal Medicine. 17th Edn. New York: The McGraw-Hill Companies, Inc.; 2008.

American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2012;35(1):64-71.

Bope ET, Kellerman RD. Conn’s Current Therapy. Saunders-Elsevier, Philadelphia, United States of America; 2014;701-704.

IDF Diabetes Atlas. 6th ed. International Diabetes Federation, 2013. Available from: Accessed on 17 November 2014.

King H, Aubert RE, Herman WH. Global burden of diabetes, 1995 2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21(9):1414-31.

Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes-estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(3):1047-53.

Sierra GN. The global pandemic of diabetes. Afr J Diabetes Med. 2009;17(11):4-8.

Unger J. Current strategies for evaluating, monitoring, and treating type 2 diabetes mellitus. Am J Med. 2008;121(6):S3-8.

Krentz AJ, Bailey CJ. Oral antidiabetic agents: current role in type 2 diabetes mellitus. Drugs. 2005;65(3):385-411.

El-Kaissi S, Sherbeeni S. Pharmacological management of type 2 diabetes mellitus: an update. Curr Diabetes Rev. 2011;7(6):392-405.

Lee D, Bergman U. Studies of drug utilization. In: Strom BL, edr. Pharmacoepidemiology. 4th edn. New York: John Wiley and Sons; 2005:401.

Upadhyay DK, Palaian S, Ravi Shankar P, Mishra P, Sah AK. Prescribing pattern in diabetic outpatients in a tertiary care teaching hospital in Nepal. J Clin Diagn Res. 2007;3:248-55.

Hassan Y, Mathialagan A, Awaisu A, Aziz NA, Yahaya R, Salhani A. Trend in the use of oral hypoglycemic agents in an outpatient pharmacy department of a tertiary hospital in Malaysia (2003-2006). Asian J Pharm Clin Res. 2009;2:40-6.

Jimoh AO, Sabir AA, Chika A, Sani Z. Pattern of antidiabetic drugs use in a diabetic outpatient clinic of a tertiary health institution in Sokoto, North-western Nigeria. J Med Sci. 2011;11:241-5.

John LJ, Arifulla M, Sreedharan J, Muttappallymyalil J, Das R, John J, et al. Age and gender-based utilisation pattern of antidiabetic drugs in Ajman, United Arab Emirates. Malay J Pharm Sci. 2012;10:79-85.

Vengurlekar S, Shukla P, Patidar P, Bafna R, Jain S. Prescribing pattern of antidiabetic drugs in Indore city hospital. Indian J Pharm Sci. 2008;70(5):637-40.

Kannan A, Kumar S. A study on drug utilization of oral hypoglycemic agents in type-2 diabetic patients. Asian J Pharm Clin Res. 2011;4:60-4.

Shamna M, Karthikeyan M. Prescription pattern of antidiabetic drugs in the outpatient departments of hospitals in Malappuram district, Kerala. J Basic Clin Physiol Pharmacol. 2011;22(4):141-3.

Dave DJ, Dikshit RK, Gandhi AM. Utilization of some newer oral antidiabetic agents in a tertiary care hospital. Nat J Physiol Pharm Pharmacol. 2012;2(2):146-51.

Kumar KS, Sreeramya G, Krishna KM, Nalini K, Kiranmai N, Vasavi P. Drug use pattern study of antidiabetics in type 2 diabetes mellitus at a tertiary care hospital in Tenali, Andhra Pradesh. Int J Inv Pharm Sci. 2013;1:162-6.

Patel B, Oza B, Patel KP, Malhotra SD, Patel VJ. Pattern of antidiabetic drugs use in type 2 diabetic patients in a medicine outpatient clinic of a tertiary care teaching hospital. Int J Basic Clin Pharmacol. 2013;2:485-91.

Sivasankari V, Manivannan E, Priyadarsini SP. Drug utilization pattern of anti-diabetic drugs in a rural area of Tamil Nadu, South India- a prospective, observational study. Int J Pharm Bio Sci. 2013;4:514-9.

Alam MS, Aqil M, Qadry SA, Kapur P, Pillai KK. Utilization pattern of oral hypoglycemic agents for diabetes mellitus type 2 patients attending out-patient department at a University hospital in New Delhi. Pharmacol Pharm. 2014;5:636-45.

Boccuzzi SJ, Wogen J, Fox J, Sung JC, Shah AB, Kim J. Utilization of oral hypoglycemic agents in a drug-insured U.S. Population. Diabetes Care. 2001;24(8):1411-5.

Johnson JA, Pohar SL, Secnik K, Yurgin N, Hirji Z. Utilization of diabetes medication and cost of testing supplies in Saskatchewan, 2001. BMC Health Serv Res. 2006;6(1):159.

Yurgin N, Secnik K, Lage MJ. Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study. Clin Ther. 2007;29(2):316-25.

Sudha V, Shukla P, Patidar P, Bafna R, Jain S. Prescribing pattern of antidiabetic drugs in Indore City Hospital Indian. J Pharm Sci. 2008;70(5):637-40.

Meneilly GS, Elliott T, Tessier D, Hards L, Tildesley H. NIDDM in the elderly. Diabetes Care. 1996;19(12):1320-5.

Rizvi AA. Management of diabetes in older adults. Am J Med Sci. 2007;333(1):35-47.

Karthikeyan V, Maadhusudhan S, Selvamuthukumran S. Studies on prescribing pattern in the management of diabetes mellitus in rural teaching hospital. Saudi J Med Pharm Sci. 2016;2(5):100-7.

Alex SM, Sreelekshmi BS, Smitha S, JijiKn MA, Devi PU. Drug utilization pattern of anti-diabetic drugs among diabetic outpatients in a tertiary care hospital. Asian J Pharm Clin Res. 2015;8(2).

Truter I. An investigation into antidiabetic medication prescribing in South Africa. J Clin Pharma Therap. 1998;23(6):417-22.

Jenny L, Arifulla M, Sreedharan J, Muttappallymyalil J, Das R. Age and gender-based utilization pattern of antidiabetic drugs in Ajman, UAE. Malay J Pharm Sci. 2012;10(1):79-85.